Eli Lilly and Company (NYSE: LLY) today announced it has acquired two investigational positron emission tomography (PET) tracers from Siemens Medical Solutions USA, Inc. The tracers are intended to image tau (or neurofibrillary) tangles in the brain, one of two known hallmarks of Alzheimer's disease. Based on studies of samples obtained at autopsy, the amount and location of tau tangles in an Alzheimer's disease patient's brain is thought to correlate with the severity of the disease. There are currently no approved diagnostics to detect tau tangles in living patients, creating challenges for scientists working to understand the progression of the disease and how therapies may impact it.

A prostate cancer patient has become the first person in the world to be treated using the latest version of Varian's Vitesse™ real time planning solution for planning and performing advanced high-dose-rate (HDR), ultrasound-guided brachytherapy treatments. The treatment took place at the Levine Cancer Institute in Charlotte, North Carolina.

The Royal Liverpool University Hospital’s interventional radiology department has recently invested in two SonoSite EDGE® hand-carried ultrasound systems to assist diagnosis and treatment of disease.

To help reduce complications and improve the accuracy and safety of interventional procedures, Toshiba America Medical Systems, Inc. extends AplioTM 500’s Smart Fusion ultrasound technology to MR.

Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology, announced today that it will demonstrate its industry-leading BK Medical-branded Flex Focus(TM) 500 ultrasound system with Quantum Technology(TM) and the Ultrasonix-branded SonixTablet(TM) with GPS needle guidance, at the 38th Annual Scientific Meeting of the Society of Interventional Radiology (SIR) in New Orleans, April 13--18.

Elekta recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to begin shipping and installation of all components of the Versa HD™ system within the United States.

Matakina International today announced the installation of Volpara objective breast density measurement software at Jacobi Medical Center (Jacobi) and North Central Bronx Hospital (NCBH), which comprise the North Bronx Healthcare Network.

Manhattan Scientifics (MHTX: OTCQB) announced today that it has received the initial $1 million of a $2.5 million commitment to build the first generation of its advanced cancer detection devices. More information can be found in the company’s recent 8-K filing.